The increase in public interest has been accompanied by substantial private-sector financial investments in the development of regenerative treatments. Such treatments, which together make up the field of regenerative medicine, may have the potential to treat a range of problems such as organ failure, traumatic injuries, and serious diseases.
Over the last two decades, cell therapies (which involve the transplantation of whole cells into a patient), gene therapies (which use genetic material to manipulate a patient’s cells), and other medical treatments intended to repair or replace damaged, diseased, or dysfunctional cells, tissues, and organs have generated increasing public interest.
0 kommentar(er)
